IDEAS home Printed from https://ideas.repec.org/e/pbl113.html
   My authors  Follow this author

Margaret E. Blume-Kohout

Personal Details

First Name:Margaret
Middle Name:Elizabeth
Last Name:Blume-Kohout
Suffix:
RePEc Short-ID:pbl113
[This author has chosen not to make the email address public]
Terminal Degree:2009 Pardee Rand Graduate School; RAND (from RePEc Genealogy)

Affiliation

Economics Department
Gettysburg College

Gettysburg, Pennsylvania (United States)
https://www.gettysburg.edu/academic-programs/economics/
RePEc:edi:edgetus (more details at EDIRC)

Research output

as
Jump to: Working papers Articles

Working papers

  1. Margaret E. Blume-Kohout & Krishna B. Kumar & Neeraj Sood, 2009. "Federal Life Sciences Funding and University R&D," NBER Working Papers 15146, National Bureau of Economic Research, Inc.
  2. Margaret E. Blume-Kohout & Neeraj Sood, 2008. "The Impact of Medicare Part D on Pharmaceutical R&D," NBER Working Papers 13857, National Bureau of Economic Research, Inc.

Articles

  1. Margaret E. Blume-Kohout, 2024. "Entrepreneurship Lock and the Demand for Health Insurance: Evidence from the US Affordable Care Act," ILR Review, Cornell University, ILR School, vol. 77(2), pages 199-226, March.
  2. Margaret E. Blume-Kohout, 2023. "The case of the interrupting funder: dynamic effects of R&D funding and patenting in U.S. universities," The Journal of Technology Transfer, Springer, vol. 48(4), pages 1221-1242, August.
  3. Margaret E. Blume-Kohout, 2023. "The Affordable Care Act and Women’s Self-Employment in the United States," Feminist Economics, Taylor & Francis Journals, vol. 29(1), pages 174-204, January.
  4. Margaret E. Blume‐Kohout & Jacob P. Scott, 2022. "Incentivizing STEM participation: Evidence from the SMART Grant Program," Southern Economic Journal, John Wiley & Sons, vol. 89(2), pages 373-405, October.
  5. Margaret E. Blume-Kohout, 2017. "The University and the Economyby Aldo Geuna and Federica Rossi," Science and Public Policy, Oxford University Press, vol. 44(1), pages 147-148.
  6. Margaret E. Blume-Kohout, 2016. "Why are some foreign-born workers more entrepreneurial than others?," The Journal of Technology Transfer, Springer, vol. 41(6), pages 1327-1353, December.
  7. Blume-Kohout, Margaret E. & Adhikari, Dadhi, 2016. "Training the scientific workforce: Does funding mechanism matter?," Research Policy, Elsevier, vol. 45(6), pages 1291-1303.
  8. Margaret E. Blume-Kohout & Krishna B. Kumar & Neeraj Sood, 2015. "University R&D Funding Strategies in a Changing Federal Funding Environment," Science and Public Policy, Oxford University Press, vol. 42(3), pages 355-368.
  9. Margaret Blume-Kohout & Krishna Kumar & Christopher Lau & Neeraj Sood, 2015. "The effect of federal research funding on formation of university-firm biopharmaceutical alliances," The Journal of Technology Transfer, Springer, vol. 40(5), pages 859-876, October.
  10. Margaret E Blume-Kohout & John W Clack, 2013. "Are Graduate Students Rational? Evidence from the Market for Biomedical Scientists," PLOS ONE, Public Library of Science, vol. 8(12), pages 1-13, December.
  11. Blume-Kohout, Margaret E. & Sood, Neeraj, 2013. "Market size and innovation: Effects of Medicare Part D on pharmaceutical research and development," Journal of Public Economics, Elsevier, vol. 97(C), pages 327-336.
  12. Margaret E. Blume-Kohout, 2012. "Does Targeted, Disease‐Specific Public Research Funding Influence Pharmaceutical Innovation?," Journal of Policy Analysis and Management, John Wiley & Sons, Ltd., vol. 31(3), pages 641-660, June.

Citations

Many of the citations below have been collected in an experimental project, CitEc, where a more detailed citation analysis can be found. These are citations from works listed in RePEc that could be analyzed mechanically. So far, only a minority of all works could be analyzed. See under "Corrections" how you can help improve the citation analysis.

Working papers

  1. Margaret E. Blume-Kohout & Krishna B. Kumar & Neeraj Sood, 2009. "Federal Life Sciences Funding and University R&D," NBER Working Papers 15146, National Bureau of Economic Research, Inc.

    Cited by:

    1. Joshua L Rosenbloom & Donna K Ginther & Ted Juhl & Joseph A Heppert, 2015. "The Effects of Research & Development Funding on Scientific Productivity: Academic Chemistry, 1990-2009," PLOS ONE, Public Library of Science, vol. 10(9), pages 1-23, September.
    2. Margaret Blume-Kohout & Krishna Kumar & Christopher Lau & Neeraj Sood, 2015. "The effect of federal research funding on formation of university-firm biopharmaceutical alliances," The Journal of Technology Transfer, Springer, vol. 40(5), pages 859-876, October.
    3. Raphaël Godefroy, 2010. "The birth of the congressional clinic," Working Papers halshs-00564921, HAL.
    4. Leila Tahmooresnejad & Catherine Beaudry & Andrea Schiffauerova, 2015. "The role of public funding in nanotechnology scientific production: Where Canada stands in comparison to the United States," Scientometrics, Springer;Akadémiai Kiadó, vol. 102(1), pages 753-787, January.
    5. Lauren Lanahan, 2016. "Multilevel public funding for small business innovation: a review of US state SBIR match programs," The Journal of Technology Transfer, Springer, vol. 41(2), pages 220-249, April.
    6. Elzbieta Pohulak-Zoledowska, 2013. "Property Rights Of Scientific Knowledge In Terms Of Creating Innovation," Oeconomia Copernicana, Institute of Economic Research, vol. 4(1), pages 37-52, March.
    7. Maryann Feldman & Lauren Lanahan, 2013. "State Science Policy Experiments," NBER Chapters, in: The Changing Frontier: Rethinking Science and Innovation Policy, pages 287-317, National Bureau of Economic Research, Inc.
    8. Beaudry, Catherine & Allaoui, Sedki, 2012. "Impact of public and private research funding on scientific production: The case of nanotechnology," Research Policy, Elsevier, vol. 41(9), pages 1589-1606.
    9. Daniel Crown & Alessandra Faggian, 2019. "Naturalization and the productivity of foreign-born doctorates," Journal of Geographical Systems, Springer, vol. 21(4), pages 533-556, December.
    10. Richard Jensen & Jerry Thursby & Marie C. Thursby, 2010. "University-Industry Spillovers, Government Funding, and Industrial Consulting," NBER Working Papers 15732, National Bureau of Economic Research, Inc.
    11. Alexander Whalley & Justin Hicks, 2014. "Spending Wisely? How Resources Affect Knowledge Production In Universities," Economic Inquiry, Western Economic Association International, vol. 52(1), pages 35-55, January.

  2. Margaret E. Blume-Kohout & Neeraj Sood, 2008. "The Impact of Medicare Part D on Pharmaceutical R&D," NBER Working Papers 13857, National Bureau of Economic Research, Inc.

    Cited by:

    1. Paul Grootendorst, 2012. "Prescription Drug Insurance and Reimbursement," Chapters, in: Andrew M. Jones (ed.), The Elgar Companion to Health Economics, Second Edition, chapter 11, Edward Elgar Publishing.
    2. Margaret K. Kyle, 2019. "The Alignment of Innovation Policy and Social Welfare: Evidence from Pharmaceuticals," NBER Chapters, in: Innovation Policy and the Economy, Volume 20, pages 95-123, National Bureau of Economic Research, Inc.
    3. Seth Freedman & Haizhen Lin & Kosali Simon, 2014. "Public Health Insurance Expansions and Hospital Technology Adoption," NBER Working Papers 20159, National Bureau of Economic Research, Inc.
    4. Jonathan D. Ketcham & Kosali Simon, 2008. "Medicare Part D's Effects on Elderly Drug Costs and Utilization," NBER Working Papers 14326, National Bureau of Economic Research, Inc.
    5. Jeffrey Clemens, 2013. "The Effect of U.S. Health Insurance Expansions on Medical Innovation," NBER Working Papers 19761, National Bureau of Economic Research, Inc.
    6. Claudio Lucarelli & Sean Nicholson & Minjae Song, 2010. "Bundling Among Rivals: A Case of Pharmaceutical Cocktails," NBER Working Papers 16321, National Bureau of Economic Research, Inc.
    7. Iain M. Cockburn & Scott Stern & Jack Zausner, 2011. "Finding the Endless Frontier: Lessons from the Life Sciences Innovation System for Energy R&D," NBER Chapters, in: Accelerating Energy Innovation: Insights from Multiple Sectors, pages 113-157, National Bureau of Economic Research, Inc.

Articles

  1. Margaret E. Blume-Kohout, 2016. "Why are some foreign-born workers more entrepreneurial than others?," The Journal of Technology Transfer, Springer, vol. 41(6), pages 1327-1353, December.

    Cited by:

    1. Michael Roach & Henry Sauermann & John Skrentny, 2019. "Are Foreign Stem PhDs More Entrepreneurial? Entrepreneurial Characteristics, Preferences and Employment Outcomes of Native and Foreign Science & Engineering PhD Students," NBER Working Papers 26225, National Bureau of Economic Research, Inc.
    2. Sinkovics, Noemi & Reuber, A. Rebecca, 2021. "Beyond disciplinary silos: A systematic analysis of the migrant entrepreneurship literature," Journal of World Business, Elsevier, vol. 56(4).
    3. Amornsiripanitch, Natee & Gompers, Paul A. & Hu, George & Vasudevan, Kaushik, 2023. "Getting schooled: Universities and VC-backed immigrant entrepreneurs," Research Policy, Elsevier, vol. 52(7).

  2. Blume-Kohout, Margaret E. & Adhikari, Dadhi, 2016. "Training the scientific workforce: Does funding mechanism matter?," Research Policy, Elsevier, vol. 45(6), pages 1291-1303.

    Cited by:

    1. Ran Xu & Navid Ghaffarzadegan, 2018. "Neuroscience bridging scientific disciplines in health: Who builds the bridge, who pays for it?," Scientometrics, Springer;Akadémiai Kiadó, vol. 117(2), pages 1183-1204, November.
    2. Natalia Maloshonok & Evgeniy Terentev, 2019. "Towards the New Model of Doctoral Education: The Experience of Enhancing Doctoral Programs in Russian Universities," Voprosy obrazovaniya / Educational Studies Moscow, National Research University Higher School of Economics, issue 3, pages 8-42.
    3. Star X. Zhao & Wen Lou & Alice M. Tan & Shuang Yu, 2018. "Do funded papers attract more usage?," Scientometrics, Springer;Akadémiai Kiadó, vol. 115(1), pages 153-168, April.
    4. Малошонок Н. Г. & Терентьев Е. А., 2019. "На Пути К Новой Модели Аспирантуры: Опыт Совершенствования Аспирантских Программ В Российских Вузах," Вопросы образования // Educational Studies Moscow, National Research University Higher School of Economics, issue 3, pages 8-42.
    5. Yu, Yan & Ibarra, Julio E. & Kumar, Kuldeep & Chergarova, Vasilka, 2021. "Coevolution of cyberinfrastructure development and scientific progress," Technovation, Elsevier, vol. 100(C).
    6. Chaojiang Wu & Erjia Yan & Yongjun Zhu & Kai Li, 2021. "Gender imbalance in the productivity of funded projects: A study of the outputs of National Institutes of Health R01 grants," Journal of the Association for Information Science & Technology, Association for Information Science & Technology, vol. 72(11), pages 1386-1399, November.
    7. Pierre Azoulay & Wesley H. Greenblatt & Misty L. Heggeness, 2019. "Long-term Effects from Early Exposure to Research: Evidence from the NIH "Yellow Berets''," NBER Working Papers 26069, National Bureau of Economic Research, Inc.
    8. Graddy-Reed, Alexandra & Lanahan, Lauren & D'Agostino, Jesse, 2021. "Training across the academy: The impact of R&D funding on graduate students," Research Policy, Elsevier, vol. 50(5).
    9. Hyungjo Hur & Maryam A Andalib & Julie A Maurer & Joshua D Hawley & Navid Ghaffarzadegan, 2017. "Recent trends in the U.S. Behavioral and Social Sciences Research (BSSR) workforce," PLOS ONE, Public Library of Science, vol. 12(2), pages 1-18, February.
    10. Margaret E Blume-Kohout & John W Clack, 2013. "Are Graduate Students Rational? Evidence from the Market for Biomedical Scientists," PLOS ONE, Public Library of Science, vol. 8(12), pages 1-13, December.

  3. Margaret E. Blume-Kohout & Krishna B. Kumar & Neeraj Sood, 2015. "University R&D Funding Strategies in a Changing Federal Funding Environment," Science and Public Policy, Oxford University Press, vol. 42(3), pages 355-368.

    Cited by:

    1. Blume-Kohout, Margaret E. & Adhikari, Dadhi, 2016. "Training the scientific workforce: Does funding mechanism matter?," Research Policy, Elsevier, vol. 45(6), pages 1291-1303.
    2. Annita Nugent & Ho Fai Chan & Uwe Dulleck, 2022. "Government funding of university-industry collaboration: exploring the impact of targeted funding on university patent activity," Scientometrics, Springer;Akadémiai Kiadó, vol. 127(1), pages 29-73, January.
    3. Rosenbloom, Joshua L. & Ginther, Donna K., 2016. "Show me the Money: Federal R&D Support for Academic Chemistry, 1990–2009," ISU General Staff Papers 201612290800001018, Iowa State University, Department of Economics.
    4. Paige Clayton & Maryann Feldman & Benjamin Montmartin, 2019. "Funding Emerging Ecosystems," GREDEG Working Papers 2019-25, Groupe de REcherche en Droit, Economie, Gestion (GREDEG CNRS), Université Côte d'Azur, France.
    5. Mikko Packalen & Jay Bhattacharya, 2018. "Does the NIH Fund Edge Science?," NBER Working Papers 24860, National Bureau of Economic Research, Inc.

  4. Margaret Blume-Kohout & Krishna Kumar & Christopher Lau & Neeraj Sood, 2015. "The effect of federal research funding on formation of university-firm biopharmaceutical alliances," The Journal of Technology Transfer, Springer, vol. 40(5), pages 859-876, October.

    Cited by:

    1. Zhou Mo & Zhang Yujie & Lei Jiasu & Tan Xiaowen, 2022. "Early firm engagement, government research funding, and the privatization of public knowledge," Scientometrics, Springer;Akadémiai Kiadó, vol. 127(8), pages 4797-4826, August.
    2. Jason Coupet & Yuhao Ba, 2022. "Benchmarking university technology transfer performance with external research funding: a stochastic frontier analysis," The Journal of Technology Transfer, Springer, vol. 47(2), pages 605-620, April.
    3. Rojas, Mariana Giovanna Andrade & Solis, Edgar Rogelio Ramirez & Zhu, John JianJun, 2018. "Innovation and network multiplexity: R&D and the concurrent effects of two collaboration networks in an emerging economy," Research Policy, Elsevier, vol. 47(6), pages 1111-1124.
    4. Byeongwoo Kang & Kazuyuki Motohashi, 2020. "Academic contribution to industrial innovation by funding type," Scientometrics, Springer;Akadémiai Kiadó, vol. 124(1), pages 169-193, July.

  5. Margaret E Blume-Kohout & John W Clack, 2013. "Are Graduate Students Rational? Evidence from the Market for Biomedical Scientists," PLOS ONE, Public Library of Science, vol. 8(12), pages 1-13, December.

    Cited by:

    1. Blume-Kohout, Margaret E. & Adhikari, Dadhi, 2016. "Training the scientific workforce: Does funding mechanism matter?," Research Policy, Elsevier, vol. 45(6), pages 1291-1303.
    2. Paula Stephan & Giuseppe Scellato & Chiara Franzoni, 2015. "International Competition for PhDs and Postdoctoral Scholars: What Does (and Does Not) Matter," Innovation Policy and the Economy, University of Chicago Press, vol. 15(1), pages 73-113.
    3. Rosenbloom, Joshua, 2022. "What Explains Science's Expanded Reliance On Postdoctoral Researchers?," ISU General Staff Papers 202209221250360000, Iowa State University, Department of Economics.
    4. Conti, Annamaria & Visentin, Fabiana, 2015. "A revealed preference analysis of PhD students’ choices over employment outcomes," Research Policy, Elsevier, vol. 44(10), pages 1931-1947.
    5. Hyungjo Hur & Navid Ghaffarzadegan & Joshua Hawley, 2015. "Effects of Government Spending on Research Workforce Development: Evidence from Biomedical Postdoctoral Researchers," PLOS ONE, Public Library of Science, vol. 10(5), pages 1-16, May.

  6. Blume-Kohout, Margaret E. & Sood, Neeraj, 2013. "Market size and innovation: Effects of Medicare Part D on pharmaceutical research and development," Journal of Public Economics, Elsevier, vol. 97(C), pages 327-336.

    Cited by:

    1. Heidi L. Williams, 2015. "Intellectual Property Rights and Innovation: Evidence from Health Care Markets," NBER Working Papers 21246, National Bureau of Economic Research, Inc.
    2. Darius Lakdawalla & Anup Malani & Julian Reif, 2015. "The Insurance Value of Medical Innovation," NBER Working Papers 21015, National Bureau of Economic Research, Inc.
    3. Shao, Chuanlin & Tao, Yunqing & Chen, Dong & Ye, Yongwei, 2023. "Curse or blessing: National industrial investment fund and corporate R&D in China," Finance Research Letters, Elsevier, vol. 54(C).
    4. Abby Alpert & Darius Lakdawalla & Neeraj Sood, 2015. "Prescription Drug Advertising and Drug Utilization: The Role of Medicare Part D," NBER Working Papers 21714, National Bureau of Economic Research, Inc.
    5. Agarwal, Ruchir & Gaule, Patrick, 2022. "What drives innovation? Lessons from COVID-19 R&D," Journal of Health Economics, Elsevier, vol. 82(C).
    6. Jeffrey P. Clemens & Morten Olsen, 2021. "Medicare and the Rise of American Medical Patenting: The Economics of User-Driven Innovation," CESifo Working Paper Series 9008, CESifo.
    7. Gamba, Simona & Magazzini, Laura & Pertile, Paolo, 2021. "R&D and market size: Who benefits from orphan drug legislation?," Journal of Health Economics, Elsevier, vol. 80(C).
    8. Lakdawalla, Darius & Sood, Neeraj & Gu, Qian, 2013. "Pharmaceutical advertising and Medicare Part D," Journal of Health Economics, Elsevier, vol. 32(6), pages 1356-1367.
    9. Kevin A. Bryan & Heidi L. Williams, 2021. "Innovation: Market Failures and Public Policies," NBER Working Papers 29173, National Bureau of Economic Research, Inc.
    10. Matteo Alvisi & Emanuela Carbonara, 2020. "Cocktails done right: price competition and welfare when substitutes become complements," Journal of Economics, Springer, vol. 131(1), pages 1-38, September.
    11. Dubois, Pierre & Gandhi, Ashvin & Vasserman, Shoshana, 2022. "Bargaining and International Reference Pricing in the Pharmaceutical Industry," Research Papers 3889, Stanford University, Graduate School of Business.
    12. Volker Grossmann, 2011. "Do Cost-sharing and Entry Deregulation Curb Pharmaceutical Innovation?," CESifo Working Paper Series 3439, CESifo.
    13. Giammario Impullitti & Richard Kneller & Danny McGowan, 2020. "Demand‐Driven Technical Change and Productivity Growth: Theory and Evidence FROM the Energy Policy Act," Journal of Industrial Economics, Wiley Blackwell, vol. 68(2), pages 328-363, June.
    14. Dubois, Pierre & de Mouzon, Olivier & Scott Morton, Fiona & Seabright, Paul, 2011. "Market Size and Pharmaceutical Innovation," IDEI Working Papers 670, Institut d'Économie Industrielle (IDEI), Toulouse, revised Mar 2014.
    15. Jeffrey Clemens & Joshua D. Gottlieb, 2017. "In the Shadow of a Giant: Medicare’s Influence on Private Physician Payments," Journal of Political Economy, University of Chicago Press, vol. 125(1), pages 1-39.
    16. Sanzenbacher, Geoffrey T. & Wettstein, Gal, 2020. "Drug insurance and the strategic behavior of drug manufacturers: Evergreening and generic entry after Medicare Part D," Journal of Health Economics, Elsevier, vol. 72(C).
    17. Hermosilla, Manuel & Wu, Yufei, 2018. "Market size and innovation: The intermediary role of technology licensing," Research Policy, Elsevier, vol. 47(5), pages 980-991.
    18. Shi-jie Jiang & Lilin Wang & Feiyun Xiang, 2023. "The Effect of Agriculture Insurance on Agricultural Carbon Emissions in China: The Mediation Role of Low-Carbon Technology Innovation," Sustainability, MDPI, vol. 15(5), pages 1-20, March.
    19. Chorniy, Anna & Bailey, James & Maloney, Michael & Civan, Abdulkadir, 2019. "Regulatory Review Time and Pharmaceutical R&D," Working Papers 06923, George Mason University, Mercatus Center.
    20. Douglas Barthold, 2014. "The Effects of Prescription Drug Cost Sharing: Evidence from the Medicare Modernization Act," Working Papers 14C001, Canadian Centre for Health Economics, revised Nov 2014.
    21. Tianyan Hu & Sandra L. Decker & Shin-Yi Chou, 2017. "The impact of health insurance expansion on physician treatment choice: Medicare Part D and physician prescribing," International Journal of Health Economics and Management, Springer, vol. 17(3), pages 333-358, September.
    22. Andreas Beerli & Franziska J. Weiss & Fabrizio Zilibotti, 2018. "Demand forces of technical change: evidence from the Chinese manufacturing industry," ECON - Working Papers 277, Department of Economics - University of Zurich.
    23. Samandar Ali Eshtehardi, Mojgan & Bagheri, Seyed Kamran & Di Minin, Alberto, 2017. "Regional innovative behavior: Evidence from Iran," Technological Forecasting and Social Change, Elsevier, vol. 122(C), pages 128-138.
    24. Eric Helland & Seth A. Seabury, 2016. "Are Settlements in Patent Litigation Collusive? Evidence from Paragraph IV Challenges," NBER Working Papers 22194, National Bureau of Economic Research, Inc.
    25. Federico Nutarelli & Massimo Riccaboni & Andrea Morescalchi, 2021. "Product recalls, market size and innovation in the pharmaceutical industry," Papers 2111.15389, arXiv.org.
    26. Massimo FLORIO, 2020. "Biomed Europa: after the coronavirus, a public infrastructure to overcome the pharmaceutical oligopoly," CIRIEC Working Papers 2008, CIRIEC - Université de Liège.
    27. Pourya Darnihamedani & Joern Hendrich Block & Jolanda Hessels & Aram Simonyan, 2015. "Start-up Costs, Taxes and Innovative Entrepreneurship," Tinbergen Institute Discussion Papers 15-013/VII, Tinbergen Institute.
    28. Mark Pauly & Kyle Myers, 2016. "A Ricardian-Demand Explanation for Changing Pharmaceutical R&D Productivity," NBER Working Papers 22720, National Bureau of Economic Research, Inc.
    29. Jeffrey Clemens & Parker Rogers, 2020. "Demand Shocks, Procurement Policies, and the Nature of Medical Innovation: Evidence from Wartime Prosthetic Device Patents," NBER Working Papers 26679, National Bureau of Economic Research, Inc.
    30. David Dranove & Craig Garthwaite & Manuel I. Hermosilla, 2020. "Expected Profits and The Scientific Novelty of Innovation," NBER Working Papers 27093, National Bureau of Economic Research, Inc.
    31. Caroline Savage Bennette & Anirban Basu & Scott D. Ramsey & Zachary Helms & Peter B. Bach, 2019. "Health Returns to Pharmaceutical Innovation in the Market for Oral Chemotherapy in Response to Insurance Coverage Expansion," American Journal of Health Economics, MIT Press, vol. 5(3), pages 360-375, Summer.
    32. Jiafeng Gu, 2021. "Spatial Dynamics between Firm Sales and Environmental Responsibility: The Mediating Role of Corporate Innovation," Sustainability, MDPI, vol. 13(4), pages 1-18, February.
    33. David B. Ridley & Chung-Ying Lee, 2020. "Does Medicare Reimbursement Drive Up Drug Launch Prices?," The Review of Economics and Statistics, MIT Press, vol. 102(5), pages 980-993, December.
    34. Anna Chorniy & James Bailey & Abdulkadir Civan & Michael Maloney, 2021. "Regulatory review time and pharmaceutical research and development," Health Economics, John Wiley & Sons, Ltd., vol. 30(1), pages 113-128, January.
    35. Blankart, Katharina & Lichtenberg, Frank R., 2022. "The effects of off-label drug use on disability and medical expenditure," Ruhr Economic Papers 969, RWI - Leibniz-Institut für Wirtschaftsforschung, Ruhr-University Bochum, TU Dortmund University, University of Duisburg-Essen.
    36. Iizuka, Toshiaki & Uchida, Gyo, 2017. "Promoting innovation in small markets: Evidence from the market for rare and intractable diseases," Journal of Health Economics, Elsevier, vol. 54(C), pages 56-65.
    37. Leila Agha & Soomi Kim & Danielle Li, 2020. "Insurance Design and Pharmaceutical Innovation," NBER Working Papers 27563, National Bureau of Economic Research, Inc.
    38. John A. Romley & Neeraj Sood, 2013. "Identifying the Health Production Function: The Case of Hospitals," NBER Working Papers 19490, National Bureau of Economic Research, Inc.
    39. Dubois, Pierre & Majewska, Gosia, 2022. "Mergers and Advertising in the Pharmaceutical Industry," CEPR Discussion Papers 17658, C.E.P.R. Discussion Papers.
    40. Higgins, Matthew J. & Yan, Xin & Chatterjee, Chirantan, 2021. "Unpacking the effects of adverse regulatory events: Evidence from pharmaceutical relabeling," Research Policy, Elsevier, vol. 50(1).
    41. Alberto Galasso & Hong Luo, 2016. "Tort Reform and Innovation," NBER Working Papers 22712, National Bureau of Economic Research, Inc.
    42. Volker Grossmann, 2021. "Medical Innovations and Ageing: A Health Economics Perspective," CESifo Working Paper Series 9387, CESifo.
    43. David Dranove & Craig Garthwaite & Christopher Heard & Bingxiao Wu, 2021. "The Economics of Medical Procedure Innovation," NBER Working Papers 29438, National Bureau of Economic Research, Inc.
    44. Kalcheva, Ivalina & McLemore, Ping & Pant, Shagun, 2018. "Innovation: The interplay between demand-side shock and supply-side environment," Research Policy, Elsevier, vol. 47(2), pages 440-461.
    45. Whaley, Christopher M. & Brown, Timothy T., 2018. "Firm responses to targeted consumer incentives: Evidence from reference pricing for surgical services," Journal of Health Economics, Elsevier, vol. 61(C), pages 111-133.
    46. Tianyan Hu & Sandra L. Decker & Shin-Yi Chou, 2014. "The Impact of Health Insurance Expansion on Physician Treatment Choice: Medicare Part D and Physician Prescribing," NBER Working Papers 20708, National Bureau of Economic Research, Inc.
    47. Matthew T. Knowles, 2022. "How access to addictive drugs affects the supply of substance abuse treatment: Evidence from Medicare Part D," Health Economics, John Wiley & Sons, Ltd., vol. 31(8), pages 1649-1675, August.
    48. Bhaven Sampat, 2022. "Second World War and the direction of medical innovation," WIPO Economic Research Working Papers 70, World Intellectual Property Organization - Economics and Statistics Division.
    49. David Besanko & David Dranove & Craig Garthwaite, 2016. "Insurance and the High Prices of Pharmaceuticals," NBER Working Papers 22353, National Bureau of Economic Research, Inc.
    50. Aggarwal, Mayank & Chakrabarti, Anindya S. & Chatterjee, Chirantan & Higgins, Matthew J., 2023. "Research and market structure: Evidence from an antibiotic-resistant pathogenic outbreak," Research Policy, Elsevier, vol. 52(1).
    51. Robert Nathenson & Michael R. Richards, 2018. "Do coverage mandates affect direct-to-consumer advertising for pharmaceuticals? Evidence from parity laws," International Journal of Health Economics and Management, Springer, vol. 18(3), pages 321-336, September.
    52. Nicholas Bagley & Benjamin Berger & Amitabh Chandra & Craig Garthwaite & Ariel D. Stern, 2018. "The Orphan Drug Act at 35: Observations and an Outlook for the Twenty-First Century," NBER Chapters, in: Innovation Policy and the Economy, Volume 19, pages 97-137, National Bureau of Economic Research, Inc.
    53. Branstetter, Lee G. & Kwon, Namho, 2018. "South Korea's transition from imitator to innovator: The role of external demand shocks," Journal of the Japanese and International Economies, Elsevier, vol. 49(C), pages 28-42.
    54. Galasso, Alberto & Luo, Hong, 2016. "Tort Reform and Innovation," CEPR Discussion Papers 11358, C.E.P.R. Discussion Papers.
    55. Colleen Carey, 2017. "Technological Change and Risk Adjustment: Benefit Design Incentives in Medicare Part D," American Economic Journal: Economic Policy, American Economic Association, vol. 9(1), pages 38-73, February.
    56. David Dranove & Craig Garthwaite & Manuel Hermosilla, 2014. "Pharmaceutical Profits and the Social Value of Innovation," NBER Working Papers 20212, National Bureau of Economic Research, Inc.
    57. Xuemeng Guo & Ke Guo & Hanzhong Zheng, 2023. "Industrial Agglomeration and Enterprise Innovation Sustainability: Empirical Evidence from the Chinese A-Share Market," Sustainability, MDPI, vol. 15(15), pages 1-26, July.
    58. Caroline S. Bennette & Anirban Basu & Scott D. Ramsey & Zachary Helms & Peter B. Bach, 2017. "Returns to Pharmaceutical Innovation in the Market for Oral Chemotherapy in Response to Insurance Coverage Expansion," NBER Working Papers 23842, National Bureau of Economic Research, Inc.
    59. Joshua Krieger & Danielle Li & Dimitris Papanikolaou, 2022. "Missing Novelty in Drug Development," The Review of Financial Studies, Society for Financial Studies, vol. 35(2), pages 636-679.
    60. Jan Malek & Melissa Newham & Jo Seldeslachts & Reinhilde Veugelers, 2024. "Acquiring R&D projects: who, when, and what? Evidence from antidiabetic drug development," Working Papers of Department of Management, Strategy and Innovation, Leuven 735739, KU Leuven, Faculty of Economics and Business (FEB), Department of Management, Strategy and Innovation, Leuven.
    61. Jillian Chown & David Dranove & Craig Garthwaite & Jordan Keener, 2019. "The Opportunities and Limitations of Monopsony Power in Healthcare: Evidence from the United States and Canada," NBER Working Papers 26122, National Bureau of Economic Research, Inc.
    62. Arzi Adbi & Chirantan Chatterjee & Matej Drev & Anant Mishra, 2019. "When the Big One Came: A Natural Experiment on Demand Shock and Market Structure in India's Influenza Vaccine Markets," Production and Operations Management, Production and Operations Management Society, vol. 28(4), pages 810-832, April.
    63. Besanko, David & Dranove, David & Garthwaite, Craig, 2020. "Insurance access and demand response: Pricing and welfare implications," Journal of Health Economics, Elsevier, vol. 73(C).
    64. Zhang, Xuan & Nie, Huihua, 2021. "Public health insurance and pharmaceutical innovation: Evidence from China," Journal of Development Economics, Elsevier, vol. 148(C).
    65. Christopher P. Adams, 2021. "CBO's Simulation Model of New Drug Development: Working Paper 2021-09," Working Papers 57010, Congressional Budget Office.

  7. Margaret E. Blume-Kohout, 2012. "Does Targeted, Disease‐Specific Public Research Funding Influence Pharmaceutical Innovation?," Journal of Policy Analysis and Management, John Wiley & Sons, Ltd., vol. 31(3), pages 641-660, June.

    Cited by:

    1. Kevin A. Bryan & Heidi L. Williams, 2021. "Innovation: Market Failures and Public Policies," NBER Working Papers 29173, National Bureau of Economic Research, Inc.
    2. David Popp, 2015. "Using Scientific Publications to Evaluate Government R&D Spending: The Case of Energy," NBER Working Papers 21415, National Bureau of Economic Research, Inc.
    3. Hongxiu Li & Horatiu Rus, 2018. "Water Innovation and Water Governance: Adaptive Responses to Regulatory Change and Extreme Weather Events," Working Papers 1801, University of Waterloo, Department of Economics, revised Jan 2018.
    4. Margaret K. Kyle, 2019. "The Alignment of Innovation Policy and Social Welfare: Evidence from Pharmaceuticals," NBER Chapters, in: Innovation Policy and the Economy, Volume 20, pages 95-123, National Bureau of Economic Research, Inc.
    5. Blume-Kohout, Margaret E. & Sood, Neeraj, 2013. "Market size and innovation: Effects of Medicare Part D on pharmaceutical research and development," Journal of Public Economics, Elsevier, vol. 97(C), pages 327-336.
    6. Margaret Blume-Kohout & Krishna Kumar & Christopher Lau & Neeraj Sood, 2015. "The effect of federal research funding on formation of university-firm biopharmaceutical alliances," The Journal of Technology Transfer, Springer, vol. 40(5), pages 859-876, October.
    7. Margaret Kyle & David Ridley & Su Zhang, 2017. "Strategic interaction among governments in the provision of a global public good," Post-Print hal-01952672, HAL.
    8. Graddy-Reed, Alexandra, 2020. "Getting ahead in the race for a cure: How nonprofits are financing biomedical R&D," Research Policy, Elsevier, vol. 49(8).
    9. Kalcheva, Ivalina & McLemore, Ping & Pant, Shagun, 2018. "Innovation: The interplay between demand-side shock and supply-side environment," Research Policy, Elsevier, vol. 47(2), pages 440-461.
    10. Bhaven Sampat, 2022. "Second World War and the direction of medical innovation," WIPO Economic Research Working Papers 70, World Intellectual Property Organization - Economics and Statistics Division.
    11. Mikko Packalen & Jay Bhattacharya, 2018. "Does the NIH Fund Edge Science?," NBER Working Papers 24860, National Bureau of Economic Research, Inc.
    12. David Popp, 2015. "Using Scientific Publications to Evaluate Government R&D Spending: The Case of Energy," CESifo Working Paper Series 5442, CESifo.
    13. Ke, Qing, 2020. "Technological impact of biomedical research: The role of basicness and novelty," Research Policy, Elsevier, vol. 49(7).
    14. Margaret E. Blume-Kohout, 2023. "The case of the interrupting funder: dynamic effects of R&D funding and patenting in U.S. universities," The Journal of Technology Transfer, Springer, vol. 48(4), pages 1221-1242, August.
    15. Yoshitsugu Kitazawa, 2012. "An improved theoretical ground for the linear feedback model and a new indicator," Discussion Papers 58, Kyushu Sangyo University, Faculty of Economics.

More information

Research fields, statistics, top rankings, if available.

Statistics

Access and download statistics for all items

Co-authorship network on CollEc

NEP Fields

NEP is an announcement service for new working papers, with a weekly report in each of many fields. This author has had 2 papers announced in NEP. These are the fields, ordered by number of announcements, along with their dates. If the author is listed in the directory of specialists for this field, a link is also provided.
  1. NEP-INO: Innovation (2) 2008-03-25 2009-07-11
  2. NEP-EDU: Education (1) 2009-07-11
  3. NEP-HEA: Health Economics (1) 2008-03-25
  4. NEP-IPR: Intellectual Property Rights (1) 2008-03-25

Corrections

All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. For general information on how to correct material on RePEc, see these instructions.

To update listings or check citations waiting for approval, Margaret Elizabeth Blume-Kohout should log into the RePEc Author Service.

To make corrections to the bibliographic information of a particular item, find the technical contact on the abstract page of that item. There, details are also given on how to add or correct references and citations.

To link different versions of the same work, where versions have a different title, use this form. Note that if the versions have a very similar title and are in the author's profile, the links will usually be created automatically.

Please note that most corrections can take a couple of weeks to filter through the various RePEc services.

IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.